These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27598026)

  • 101. Evaluating the Effectiveness of Interventions on Increasing Participation in Cervical Cancer Screening.
    Kurt G; Akyuz A
    J Nurs Res; 2019 Oct; 27(5):e40. PubMed ID: 30908429
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses.
    Arbyn M; Smith SB; Temin S; Sultana F; Castle P;
    BMJ; 2018 Dec; 363():k4823. PubMed ID: 30518635
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Papanicolaou staining--a review.
    Marshall PN
    Microsc Acta; 1983 May; 87(3):233-43. PubMed ID: 6195507
    [TBL] [Abstract][Full Text] [Related]  

  • 104. HPV Vaccine: Updates and Highlights.
    de Oliveira CM; Fregnani JHTG; Villa LL
    Acta Cytol; 2019; 63(2):159-168. PubMed ID: 30870844
    [TBL] [Abstract][Full Text] [Related]  

  • 105. The precision prevention and therapy of HPV-related cervical cancer: new concepts and clinical implications.
    Hu Z; Ma D
    Cancer Med; 2018 Oct; 7(10):5217-5236. PubMed ID: 30589505
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Cancer of the cervix uteri.
    Bhatla N; Aoki D; Sharma DN; Sankaranarayanan R
    Int J Gynaecol Obstet; 2018 Oct; 143 Suppl 2():22-36. PubMed ID: 30306584
    [TBL] [Abstract][Full Text] [Related]  

  • 107. A review of image analysis and machine learning techniques for automated cervical cancer screening from pap-smear images.
    William W; Ware A; Basaza-Ejiri AH; Obungoloch J
    Comput Methods Programs Biomed; 2018 Oct; 164():15-22. PubMed ID: 30195423
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Cervical Colposcopy: Indications and Risk Assessment.
    Burness JV; Schroeder JM; Warren JB
    Am Fam Physician; 2020 Jul; 102(1):39-48. PubMed ID: 32603071
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Cervical cancer control limiting factors and facilitators: a literature review.
    Lopes VAS; Ribeiro JM
    Cien Saude Colet; 2019 Sep; 24(9):3431-3442. PubMed ID: 31508761
    [TBL] [Abstract][Full Text] [Related]  

  • 110. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
    Gilham C; Sargent A; Kitchener HC; Peto J
    Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Comparison of the diagnostic value of the visual inspection with acetic acid (VIA) and Pap smear in cervical cancer screening.
    Vahedpoor Z; Behrashi M; Khamehchian T; Abedzadeh-Kalahroudi M; Moravveji A; Mohmadi-Kartalayi M
    Taiwan J Obstet Gynecol; 2019 May; 58(3):345-348. PubMed ID: 31122522
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Awareness and Knowledge of Human Papilloma Virus and Cervical Cancer in Women with High Pap Uptake.
    Alafifi R; Kindratt TB; Pagels P; Saleh N; Gimpel NE
    J Community Health; 2019 Apr; 44(2):332-338. PubMed ID: 30415376
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Human papillomavirus 9-valent vaccine for cancer prevention: a systematic review of the available evidence.
    Signorelli C; Odone A; Ciorba V; Cella P; Audisio RA; Lombardi A; Mariani L; Mennini FS; Pecorelli S; Rezza G; Zuccotti GV; Peracino A
    Epidemiol Infect; 2017 Jul; 145(10):1962-1982. PubMed ID: 28446260
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Cervical Cancer: Prevention and Early Detection.
    Kessler TA
    Semin Oncol Nurs; 2017 May; 33(2):172-183. PubMed ID: 28343836
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Cervical Cancer Screening-Past, Present, and Future.
    Wentzensen N; Clarke MA
    Cancer Epidemiol Biomarkers Prev; 2021 Mar; 30(3):432-434. PubMed ID: 33857013
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Opinions of the Urban Women on Pap test: Evidence from Bangladesh.
    Mustari S; Hossain B; Diah NM; Kar S
    Asian Pac J Cancer Prev; 2019 Jun; 20(6):1613-1620. PubMed ID: 31244279
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Systemic therapy in cervical cancer: 30 years in review.
    Liontos M; Kyriazoglou A; Dimitriadis I; Dimopoulos MA; Bamias A
    Crit Rev Oncol Hematol; 2019 May; 137():9-17. PubMed ID: 31014518
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Barriers to the non-acceptance of cervical cancer screenings (pap smear test) in women of childbearing age in a rural area of Peru.
    Olaza-Maguiña AF; De la Cruz-Ramirez YM
    Ecancermedicalscience; 2019; 13():901. PubMed ID: 30915159
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Cervical cancer and pap smear screening: knowledge, attitude and practice among working women in northern state of Malaysia.
    Romli R; Shahabudin S; Saddki N; Mokhtar N
    Med J Malaysia; 2019 Feb; 74(1):8-14. PubMed ID: 30846655
    [TBL] [Abstract][Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.